These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1828 related articles for article (PubMed ID: 26972052)

  • 1. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk.
    Zhu W; Gregory JC; Org E; Buffa JA; Gupta N; Wang Z; Li L; Fu X; Wu Y; Mehrabian M; Sartor RB; McIntyre TM; Silverstein RL; Tang WHW; DiDonato JA; Brown JM; Lusis AJ; Hazen SL
    Cell; 2016 Mar; 165(1):111-124. PubMed ID: 26972052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk.
    Zhu W; Buffa JA; Wang Z; Warrier M; Schugar R; Shih DM; Gupta N; Gregory JC; Org E; Fu X; Li L; DiDonato JA; Lusis AJ; Brown JM; Hazen SL
    J Thromb Haemost; 2018 Sep; 16(9):1857-1872. PubMed ID: 29981269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission of atherosclerosis susceptibility with gut microbial transplantation.
    Gregory JC; Buffa JA; Org E; Wang Z; Levison BS; Zhu W; Wagner MA; Bennett BJ; Li L; DiDonato JA; Lusis AJ; Hazen SL
    J Biol Chem; 2015 Feb; 290(9):5647-60. PubMed ID: 25550161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial Transplantation With Human Gut Commensals Containing CutC Is Sufficient to Transmit Enhanced Platelet Reactivity and Thrombosis Potential.
    Skye SM; Zhu W; Romano KA; Guo CJ; Wang Z; Jia X; Kirsop J; Haag B; Lang JM; DiDonato JA; Tang WHW; Lusis AJ; Rey FE; Fischbach MA; Hazen SL
    Circ Res; 2018 Oct; 123(10):1164-1176. PubMed ID: 30359185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remodelling of gut microbiota by Berberine attenuates trimethylamine N-oxide-induced platelet hyperreaction and thrombus formation.
    Xie Z; Liu X; Huang X; Liu Q; Yang M; Huang D; Zhao P; Tian J; Wang X; Hou J
    Eur J Pharmacol; 2021 Nov; 911():174526. PubMed ID: 34599914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease.
    Gupta N; Buffa JA; Roberts AB; Sangwan N; Skye SM; Li L; Ho KJ; Varga J; DiDonato JA; Tang WHW; Hazen SL
    Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1239-1255. PubMed ID: 32212854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbes impact stroke severity via the trimethylamine N-oxide pathway.
    Zhu W; Romano KA; Li L; Buffa JA; Sangwan N; Prakash P; Tittle AN; Li XS; Fu X; Androjna C; DiDonato AJ; Brinson K; Trapp BD; Fischbach MA; Rey FE; Hajjar AM; DiDonato JA; Hazen SL
    Cell Host Microbe; 2021 Jul; 29(7):1199-1208.e5. PubMed ID: 34139173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.
    Romano KA; Vivas EI; Amador-Noguez D; Rey FE
    mBio; 2015 Mar; 6(2):e02481. PubMed ID: 25784704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.
    Haissman JM; Haugaard AK; Ostrowski SR; Berge RK; Hov JR; Trøseid M; Nielsen SD
    BMC Infect Dis; 2017 Jun; 17(1):445. PubMed ID: 28645263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbial Metabolite Trimethylamine N-Oxide Is Related to Thrombus Formation in Atrial Fibrillation Patients.
    Gong D; Zhang L; Zhang Y; Wang F; Zhao Z; Zhou X
    Am J Med Sci; 2019 Dec; 358(6):422-428. PubMed ID: 31666184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial tissue factor contributes to trimethylamine N-oxide-enhanced arterial thrombosis.
    Witkowski M; Witkowski M; Friebel J; Buffa JA; Li XS; Wang Z; Sangwan N; Li L; DiDonato JA; Tizian C; Haghikia A; Kirchhofer D; Mach F; Räber L; Matter CM; Tang WHW; Landmesser U; Lüscher TF; Rauch U; Hazen SL
    Cardiovasc Res; 2022 Jul; 118(10):2367-2384. PubMed ID: 34352109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonlethal Inhibition of Gut Microbial Trimethylamine N-oxide Production Improves Cardiac Function and Remodeling in a Murine Model of Heart Failure.
    Organ CL; Li Z; Sharp TE; Polhemus DJ; Gupta N; Goodchild TT; Tang WHW; Hazen SL; Lefer DJ
    J Am Heart Assoc; 2020 May; 9(10):e016223. PubMed ID: 32390485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blueberry intervention mitigates detrimental microbial metabolite trimethylamine N-oxide by modulating gut microbes.
    Satheesh Babu AK; Petersen C; Iglesias-Carres L; Paz HA; Wankhade UD; Neilson AP; Anandh Babu PV
    Biofactors; 2024; 50(2):392-404. PubMed ID: 37921575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine Decreases Thrombosis Potential Induced by a High-choline Diet by Inhibiting CutC Enzyme.
    Qu H; Zhang Y; Shi JH; Zhao YH; Gao J; Gao ZY; Shi DZ
    Curr Med Chem; 2024; 31(24):3844-3856. PubMed ID: 37226795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease risk.
    Li XS; Wang Z; Cajka T; Buffa JA; Nemet I; Hurd AG; Gu X; Skye SM; Roberts AB; Wu Y; Li L; Shahen CJ; Wagner MA; Hartiala JA; Kerby RL; Romano KA; Han Y; Obeid S; Lüscher TF; Allayee H; Rey FE; DiDonato JA; Fiehn O; Tang WHW; Hazen SL
    JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of trimethylamine-N-oxide can be increased with 'healthy' and 'unhealthy' diets and do not correlate with the extent of atherosclerosis but with plaque instability.
    Koay YC; Chen YC; Wali JA; Luk AWS; Li M; Doma H; Reimark R; Zaldivia MTK; Habtom HT; Franks AE; Fusco-Allison G; Yang J; Holmes A; Simpson SJ; Peter K; O'Sullivan JF
    Cardiovasc Res; 2021 Jan; 117(2):435-449. PubMed ID: 32267921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota-Dependent Trimethylamine N-Oxide Predicts Risk of Cardiovascular Events in Patients With Stroke and Is Related to Proinflammatory Monocytes.
    Haghikia A; Li XS; Liman TG; Bledau N; Schmidt D; Zimmermann F; Kränkel N; Widera C; Sonnenschein K; Haghikia A; Weissenborn K; Fraccarollo D; Heimesaat MM; Bauersachs J; Wang Z; Zhu W; Bavendiek U; Hazen SL; Endres M; Landmesser U
    Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2225-2235. PubMed ID: 29976769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of gut microbial metabolite trimethylamine N-oxide (TMAO) on platelets and endothelial cells.
    Krüger-Genge A; Jung F; Hufert F; Jung EM; Küpper JH; Storsberg J
    Clin Hemorheol Microcirc; 2020; 76(2):309-316. PubMed ID: 32925010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbe-derived metabolite trimethylamine N-oxide accelerates fibroblast-myofibroblast differentiation and induces cardiac fibrosis.
    Yang W; Zhang S; Zhu J; Jiang H; Jia D; Ou T; Qi Z; Zou Y; Qian J; Sun A; Ge J
    J Mol Cell Cardiol; 2019 Sep; 134():119-130. PubMed ID: 31299216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin alleviates choline diet-induced TMAO elevation in C57BL/6J mice by influencing gut-microbiota composition and functionality.
    Su C; Li X; Yang Y; Du Y; Zhang X; Wang L; Hong B
    Nutr Diabetes; 2021 Jul; 11(1):27. PubMed ID: 34389700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 92.